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Abstract 
In clinical populations substantial heterogeneity exists in patient characteristics, illness severity and 
treatment responses. Better understanding of such heterogeneity may lead to more effective and 
efficient treatment by personalising care to better suit patient profiles. In this editorial we argue that 
the statistical method of cluster analysis is a means by which such heterogeneity can be understood, 
potentially leading to improved care in mental health services. The method is as yet relatively under-
utilised and as such the barriers to its use and implementation are also considered.  
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Introduction  
In clinical populations substantial heterogeneity exists in patient characteristics, illness severity and 
treatment responses. Better understanding of such heterogeneity may lead to more effective and 
efficient treatment by personalising care to better suit patient profiles. In this editorial we argue that 
the statistical method of cluster analysis is a means by which such heterogeneity can be understood, 
potentially leading to improved care in mental health services. The method is as yet relatively under-
utilised and as such the barriers to its use and implementation are also considered.  
Cluster analysis is a statistical method that identifies subgroups as defined by multiple characteristics. 
For example in depression there is heterogeneity in terms of age of onset (e.g. early versus late onset), 
exposure to life stress (Van den Berg et al., 2001) and severity of depression (e.g. mild, moderate or 
major depressive disorder) (Merikangas et al., 1994). Cluster analysis could help to identify subgroups 
within this patient population defined by the characteristics of age, stress exposure and depression 
severity all together. Use of such analysis could have several benefits including the development of 
diagnostic criteria, explanations of heterogeneous outcomes and tailoring of treatments (Taylor et al., 
2001; Song & Jason, 2005). We use the word ‘subgroup’ to refer to subsets of individuals within a given 
population that can be described using several characteristics. The use of this term should not be 
confused with what is traditionally called ‘subgroup analysis’ in the clinical trials literature. Subgroup 
analysis in that literature refers to quantification of treatment responses in subsets of individuals 
identifiable by a single characteristic (e.g. a demographic or psychological variable). This may involve 
analysis within the subgroup of interest, or via simple regression models including interaction terms 
(moderation analysis) (Assmann et al., 2000). Instead, this paper provides a brief overview of cluster 
analysis, how it can be used to identify subgroups, the usefulness of such analysis and its potential 
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application to clinical practice. We use some recent results in irritable bowel syndrome to illustrate 
these points. 
Diagnostic utility  
 Mental and physical health diagnostic criteria are often criticised because they are considered to be too 
restrictive, too broad or to actually exclude important factors within a given condition (Bentall & Pilgrim, 
1999; Wakefield, 2010). In irritable bowel syndrome (IBS) there are four subgroups defined by a single 
parameter - the predominant bowel pattern. Individuals can either be constipation predominant (IBS-C), 
diarrhoea predominant (IBS-D), alternating (IBS-A) or unclassified (IBS-U). However, assigning individuals 
to subgroups based on one parameter may limit the diagnostic utility and clinical relevance. Increasing 
the multidimensionality of the clinical profile of IBS subgroups could aid healthcare professionals in 
making positive diagnoses of IBS as opposed to diagnosis by exclusion. Improving clarity and validity of 
diagnostic criteria would also have the benefit of reducing the cost associated with diagnosis by 
exclusion, which often involves additional consultations and unnecessary diagnostic procedures. It also 
has a negative effect on the prognosis and illness trajectories of IBS patients as it leaves them with 
feelings of uncertainty regarding their condition and can lessen trust in healthcare professionals (Spiegel 
et al., 2010). 
Multidimensionality of IBS clinical profiles has been examined using mixture modelling cluster analysis, 
which included measures of bowel symptom type (IBS-C, IBS-D, IBS-A), symptom severity, the 
occurrence of extra-intestinal symptoms, anxiety and depression (Polster et al., 2017). Six subgroups 
were found, identified by bowel pattern subtype and further subdivided by high or low ratings of 
comorbidities (somatic and psychological). Whilst supporting the distinctions between bowel patterns, 
the results indicate that assessments of additional somatic and psychological comorbidities are also 
important factors in distinguishing IBS subtypes. Furthermore, when the groups were compared on 
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symptom severity and anxiety and depression, high comorbidity groups were found to have significantly 
higher levels of symptom severity, anxiety and depression than low comorbidity subgroups. Level of 
comorbidity therefore appears to be an important factor in distinguishing levels of symptom severity 
and psychological distress in IBS. Increasing the multidimensionality of subgroups in IBS could provide a 
means of understanding heterogeneity in outcomes that subgrouping by bowel pattern alone cannot.   
How can cluster analyses improve treatment approaches? 
The more comprehensive characterisation of subgroups provided by cluster analysis can help target 
treatments more specifically. For example in IBS, cognitive behavioural therapy (CBT) is the primary 
recommended treatment approach (Spence & Moss-Morris, 2007; Drossman, 2016). CBT aims to change 
unhelpful cognitions and behaviours contributing to the maintenance of symptoms. When assessing 
subgroups in IBS, including a measure of such tendencies to engage in unhelpful cognitive and 
behavioural patterns along with other empirically directed characteristic measures (such as anxiety and 
bowel pattern subtype) can inform how the different subgroups may be best targeted by CBT. For 
example two hypothetical subgroups identified by cluster analysis may be (1) individuals with IBS-D and 
IBS-A with higher levels of gastrointestinal avoidance behaviour and high levels of general anxiety 
compared with (2) individuals with IBS-C who have high levels of safety behaviours and gastrointestinal 
(but not general) anxiety. The characterisations of these groups by the different measures included in 
the cluster analysis would therefore provide a basis for tailoring treatment for the subgroups. For 
instance group 1 may benefit from behavioural experiments designed to demonstrate the likelihood of 
having an accident in public and stress management training to reduce general anxiety. In contrast, 
group 2 may benefit from cognitive restructuring regarding fears about not passing stools and 
behavioural exposure techniques to reduce anxiety specific to the experience of gastrointestinal 
sensations. The efficacy of such tailoring could be tested in an experimental design comparing the 
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conditions and a control group with use of moderation analysis.  In the context of randomised controlled 
trials, moderation analysis including clusters (subgroups) would identify whether there is an interaction 
between cluster membership (e.g. subgroup) and treatment group. In this example, moderation would 
determine whether membership of group 1 or 2 would affect treatment response in the different 
conditions.  
Methodological Approaches to the Identification of Subgroups   
There are numerous approaches available to researchers intending to identify subgroups that exist 
under the umbrella term of ‘cluster analysis’ (Nathan & Langenbucher, 2003). One of the most popular 
methods is finite mixture modelling, such as latent class analysis (LCA) (Stahl & Sallis, 2012). LCA 
operates on the assumption that a given dataset includes a mixture of scores from different underlying 
latent classes (subgroups)(Stahl & Sallis, 2012). The approach deduces information about the underlying 
distributions of the subgroups by identifying similar patterns of values and assessing the probability that 
certain cases are members of the identified subgroups (Fraley & Raftery, 1998). The LCA algorithm 
derives a range of subgroups from the data, and uses a goodness of fit statistic such as the Bayesian 
Information Criteria (BIC) (Nylund et al., 2007) to  identify the optimal number of subgroups that 
adequately explains the distribution of the data. For example, an LCA may identify one model with 5 
subgroups (also termed clusters or classes) and one with 4 subgroups. It will use the BIC goodness of fit 
statistic to identify which model best fits the observed data.  
This method of identifying the optimal number of subgroups is a key advantage of LCA compared to 
other methods of cluster analysis such as distance based cluster analysis that use more arbitrary 
criterion. Other advantages of LCA include its ability to combine both continuous and categorical 
measures to define subgroups and allow for the inclusion of covariates and modelling of directional 
relationships. This means LCA can control for potential effects of other background variables and when 
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used in prospective data, can be used to assess directional relationships (e.g. whether cluster 
membership predicts outcome) (Hagenaars & McCutcheon, 2002; Stahl & Sallis, 2012). 
Barriers to Implementation  
Although cluster methods provide a powerful tool for understanding subgroups and differences in 
treatment response they also require careful consideration prior to implementation.  Good statistical 
power is necessary for robust results (Lanza & Rhoades, 2013). Sample size depends on the number of 
clusters being identified and the number of items/variables entered into the analysis (Dziak et al., 2014). 
There is no consensus on an adequate sample size , but previous research suggests samples above 200 
are necessary to achieve sufficient power (Tekle et al., 2016), with some suggesting a minimum sample 
of 500 (Finch & Bronk, 2011). A strong empirical and/or theoretically informed basis for such analysis is 
vital  to inform which measures are included in analysis and the extent to which clusters identified make 
theoretical/clinical sense (Breckenridge, 1989). Replication is also essential as the models derived from 
the analysis use the existing data distribution so further samples are needed to test the robustness of 
the models (Milligan, 1996). It is therefore recommended that two datasets are used or a large enough 
dataset that allows splitting the data in two samples. One sample is then used as the ‘training’ dataset 
and the other is used as a validation sample (Everitt et al., 2001). Only once the identification of 
subgroups within a given population has been replicated (cross-validated) in multiple samples would 
there be a strong enough basis for updating existing diagnostic criteria and informing practice.  
Conclusion 
Cluster analysis is important for understanding the heterogeneity of clinical disorders, particularly those 
that challenge customary distinctions between physical and psychological aetiology. Cluster analysis 
methods can improve diagnostic criteria to provide more comprehensive and clinically meaningful 
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profiles within a condition. In IBS this involves consideration of psychological aspects such as anxiety and 
in the future a wider approach including cognitive and behavioural factors. Cluster analysis also has the 
potential to improve our understanding of differential treatment responses in different patient 
subgroups and to provide more personalised treatment to enhance recovery.  
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